Neuroscience News and Research

RSS

Alzheimer's research demonstrates cell-to-cell transmission of neurodegenerative proteins

Injecting synthetic tau fibrils into animal models induces Alzheimer's-like tau tangles and imitates the spread of tau pathology, according to research from the Perelman School of Medicine at the University of Pennsylvania being presented at the American Academy of Neurology's 65th Annual Meeting in San Diego March 16-23, 2013.

16 Mar 2013

Luminex collaborates with Merck to design companion diagnostic device for Alzheimer’s disease

WHITEHOUSE STATION known as MSD outside the United States and Canada, and Luminex Corporation have signed a collaboration and license agreement to develop a companion diagnostic device that will be evaluated to help screen patients for recruitment into Merck's clinical development program for MK-8931, a novel oral beta amyloid precursor protein site cleaving enzyme (BACE) inhibitor and Merck's lead investigational candidate for Alzheimer's disease (AD).

From Luminex 15 Mar 2013

Promising studies for Parkinson's to be presented at 65th AAN meeting

Three studies released today present possible positive news for people with Parkinson's disease. The studies, which will be presented at the American Academy of Neurology's 65th Annual Meeting in San Diego, March 16 to 23, 2013, report on treatments for blood pressure problems, the wearing-off that can occur when people have taken the main drug for Parkinson's for a long time, and for people early in the disease whose symptoms are not well-controlled by their main drugs.

15 Mar 2013

New hunt for intrinsic mechanism linked to schizophrenia

Since the 1960s, psychiatrists have been hunting for substances made by the body that might accumulate in abnormally high levels to produce the symptoms associated with schizophrenia. In particular, there was a search for chemicals that might be related to the hallucinogens phencyclidine (PCP) or lysergic acid diethylamide (LSD), which could explain the emergence of psychotic symptoms in schizophrenia.

15 Mar 2013

Researchers show inhibiting brain's filter can boost performance for tasks

The brain's prefrontal cortex is thought to be the seat of cognitive control, working as a kind of filter that keeps irrelevant thoughts, perceptions and memories from interfering with a task at hand.

15 Mar 2013

Max Planck Florida Institute for Neuroscience gets grant for research into neurological disorders

The Max Planck Florida Institute for Neuroscience, the first and only U.S. extension of the prestigious Max Planck Society, today announced it has received approximately $1,257,500 in grant funding from prestigious national and international organizations to fund research into Parkinson-s, epilepsy and other neurological disorders.

15 Mar 2013

Prescribing attention-boosting drugs for healthy kids is misguided

The American Academy of Neurology (AAN), the world's largest professional association of neurologists, is releasing a position paper on how the practice of prescribing drugs to boost cognitive function, or memory and thinking abilities, in healthy children and teens is misguided.

14 Mar 2013

UH Case Medical Center joins elite group of providers focused on complex stroke care

University Hospitals (UH) Case Medical Center has become the first hospital in Northeast Ohio and 19th in the nation to achieve The Joint Commission's standards for Comprehensive Stroke Center Certification, joining an elite group of providers focused on complex stroke care.

14 Mar 2013

GABA neuronal deficits in psychiatric disorder can be prevented using N-acetylcysteine: Study

Gamma-aminobutyric acid (GABA) deficits have been implicated in schizophrenia and depression. In schizophrenia, deficits have been particularly well-described for a subtype of GABA neuron, the parvalbumin fast-spiking interneurons.

14 Mar 2013

Stimulating brain using magnetic stimulation may improve cognitive function, say scientists

Cognitive impairments are disabling for individuals with schizophrenia, and no satisfactory treatments currently exist. These impairments affect a wide range of cognition, including memory, attention, verbal and motor skills, and IQ.

14 Mar 2013

Brain imaging can detect tiny lesions that may provide target for treating people with mTBI: Study

Brain imaging soon after mild traumatic brain injury or mild concussion can detect tiny lesions that may eventually provide a target for treating people with mTBI, according to a study released today and that will be presented at the American Academy of Neurology's 65th Annual Meeting in San Diego, March 16 to 23, 2013.

13 Mar 2013

Biomedical professor details research progress toward reading, writing neural code

Despite many remarkable discoveries in the field of neuroscience during the past several decades, researchers have not been able to fully crack the brain's "neural code."

13 Mar 2013

Research findings could lead to new sleep therapies to improve memory disorders

A team of sleep researchers led by UC Riverside psychologist Sara C. Mednick has confirmed the mechanism that enables the brain to consolidate memory and found that a commonly prescribed sleep aid enhances the process.

13 Mar 2013

Stem cells from patient’s own fat may deliver new treatments to glioblastoma

In laboratory studies, Johns Hopkins researchers say they have found that stem cells from a patient's own fat may have the potential to deliver new treatments directly into the brain after the surgical removal of a glioblastoma, the most common and aggressive form of brain tumor.

13 Mar 2013

DeStress for Success Program effective in reducing depressive symptoms among adolescents

Families with a child completing elementary school this year are now preparing their registration for high school, a transition that is often stressful for children. A new program has demonstrated that it is possible to significantly reduce stress in some of these children thanks to a new educational tool designed under the leadership of Sonia Lupien, Director of the Centre for Studies on Human Stress (CSHS) and professor at the University of Montreal.

12 Mar 2013

Results from Orion Pharma’s ORM-12741 phase IIa study on AD

A new drug may improve memory problems in people with moderate Alzheimer's disease, according to a phase IIa study released today that will be presented at the American Academy of Neurology's 65th Annual Meeting in San Diego, March 16 to 23, 2013. The drug is called ORM-12741.

12 Mar 2013

Combination of INF and glatiramer acetate does not reduce MS progression

A recent clinical trial found that interferonβ-1a (INF) and glatiramer acetate (GA), two of the most commonly prescribed drugs for multiple sclerosis (MS), provide no additional clinical benefit when taken together.

12 Mar 2013

K. Hovnanian Children's opens Meridian Health Pediatric Surgical Associates in Ocean County

K. Hovnanian Children's Hospital at Jersey Shore is expanding its surgical services with the opening of Meridian Health Pediatric Surgical Associates in Ocean County, an outpatient center dedicated to providing the region's children with a comprehensive, child-friendly and family-oriented surgical program. As the only pediatric surgery office in the southern New Jersey area, families will have access to pediatric surgical experts from Meridian Pediatric Network, the largest provider of pediatric care in Monmouth and Ocean counties.

12 Mar 2013

Buphenyl may protect memory and prevent progression of Alzheimer's

Buphenyl, an FDA-approved medication for hyperammonemia, may protect memory and prevent the progression of Alzheimer's disease.

12 Mar 2013

Early detection of PML may help improve survival and disability levels

The drug natalizumab is effective for treating multiple sclerosis (MS), but it increases the risk of a rare but potentially fatal brain infection called progressive multifocal leukoencephalopathy (PML).

11 Mar 2013

Neuroscience News and Research

Alzheimer's research demonstrates cell-to-cell transmission of neurodegenerative proteins

Luminex collaborates with Merck to design companion diagnostic device for Alzheimer’s disease

Promising studies for Parkinson's to be presented at 65th AAN meeting

New hunt for intrinsic mechanism linked to schizophrenia

Researchers show inhibiting brain's filter can boost performance for tasks

Max Planck Florida Institute for Neuroscience gets grant for research into neurological disorders

Prescribing attention-boosting drugs for healthy kids is misguided

UH Case Medical Center joins elite group of providers focused on complex stroke care

GABA neuronal deficits in psychiatric disorder can be prevented using N-acetylcysteine: Study

Stimulating brain using magnetic stimulation may improve cognitive function, say scientists

Brain imaging can detect tiny lesions that may provide target for treating people with mTBI: Study

Biomedical professor details research progress toward reading, writing neural code

Research findings could lead to new sleep therapies to improve memory disorders

Stem cells from patient’s own fat may deliver new treatments to glioblastoma

DeStress for Success Program effective in reducing depressive symptoms among adolescents

Results from Orion Pharma’s ORM-12741 phase IIa study on AD

Combination of INF and glatiramer acetate does not reduce MS progression

K. Hovnanian Children's opens Meridian Health Pediatric Surgical Associates in Ocean County

Buphenyl may protect memory and prevent progression of Alzheimer's

Early detection of PML may help improve survival and disability levels

Event guide: 8th Neuroimmunology Drug Development Summit 2026 eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News